Prostate cancer is the second most common form of cancer found in men worldwide, affecting one out of nine at some point in their lives. It’s also the second leading cause of cancer death among men in ...

The LynxDx leadership team. In the front row (from left to right) are: Spencer Heaton, Chief Medical and Commercial Officer; Steve Riggs, President; and Jeff Crays, Chief Technology Officer. In the ...

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

Prostate cancer is the second most common cancer in men, with over 288,000 new cases diagnosed each year. It is also one of the most curable cancers if detected early. A new imaging tool is helping ...

A new study from the UK has suggested a new way to “significantly” reduce prostate cancer deaths. It says that a simple, 10-minute MRI (Magnetic Resonance Imaging) scan can pick up more early-stage ...

If you or a loved one are navigating the journey of prostate cancer, you know that every decision weighs heavily. You’ve likely faced surgery or initial treatments, only to encounter the fear that ...

Older men across Lancashire have been urged to take an annual prostate cancer test after an MP with a family history of the disease described the county's screening rate as "really poor". South Ribble ...

“With this test, it could be possible to turn the tide on prostate cancer. We have shown that a relatively simple, inexpensive spit test to identify men of European heritage at higher risk due to ...

SAN DIEGO -- An algorithm-based decision tool eliminated inappropriate prescribing of bone-modifying agents (BMA) in patients with advanced prostate cancer, according to a VA-based study. Prior to ...

Prostate cancer remains the second most common form of cancer found in men worldwide and is the second leading cause of cancer death among men in the U.S. Screening for prostate cancer can help to ...

Scientists at the University of Cambridge, in collaboration with researchers at the Institute of Cancer Research, London, have developed a new computational algorithm to help predict a man's ...